Blood Flow Restricted Resistance Training in Peripheral Arterial Disease

Sponsor
Sheffield Hallam University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04890275
Collaborator
Sheffield Teaching Hospitals NHS Foundation Trust (Other)
30
1
2
15.3
2

Study Details

Study Description

Brief Summary

A randomised controlled trial evaluating the feasibility and acceptability of a 12 week lower body blood flow restricted resistance exercise programme for people with peripheral arterial disease.

Condition or Disease Intervention/Treatment Phase
  • Other: Blood flow restricted resistance exercise (BFR)
  • Other: Resistance exercise without blood flow restricted (NON-BFR)
N/A

Detailed Description

The primary aim of this study is to determine the feasibility of 12 weeks of lower body resistance exercise performed with blood flow restriction (BFR) in people with peripheral arterial disease.

Resistance exercise with BFR involves placing inflatable cuffs proximal to the exercise limbs in order to manipulate blood flow and enhance the training response.

Secondary aim of this study is to evaluate changes in ABPI, muscle size, strength and physical function at mid-and post- intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Blood Flow Restricted Resistance Training in Peripheral Arterial Disease: a Randomised Controlled Trial Feasibility Study
Actual Study Start Date :
Apr 21, 2021
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: BFR

Participants will participate in a supervised low load lower body blood flow restriction resistance exercise program twice a week for 12 weeks

Other: Blood flow restricted resistance exercise (BFR)
Following a 5-minute low intensity warm-up, the BFR cuff will be placed at the most proximal portion of the leg inflated to 50% limb occlusion following standard BFR guidelines. Participants will then perform leg press including 1 set of 30 reps, then 3 sets of 15 reps at 20% 1RM. Rest for 5 minutes without cuff inflation. Cuffs will be re inflated and participants will perform knee extension including 3 x 15 repetitions at 20% 1RM.

Active Comparator: NON-BFR

Participants will participate in a supervised low load lower resistance exercise program twice a week for 12 weeks (matched training volume as experimental arm but without BFR)

Other: Resistance exercise without blood flow restricted (NON-BFR)
Participants will follow the same exercise protocol as the blood flow restriction group but with out BFR.

Outcome Measures

Primary Outcome Measures

  1. Recruitment Rates [3 months]

    Defined as rate of invited participants who are eligible and consenting.

  2. Retention Rates [3 months]

    Retention rates will be established as discontinuation with the exercise intervention and absence from the assessment sessions.

  3. Acceptability of allocation [3 months]

    will be assessed by attrition rates, comparing participant withdrawal between experimental and control groups and reasons for dropout where appropriate.

  4. Acceptability of the exercise study [3 months]

    Will be evaluated by participants feedback via one-to-one semi-structured interviews.

  5. Completion Rates [3 months]

    Completion is determined by participants that attend baseline testing and post exercise intervention testing.

Secondary Outcome Measures

  1. Change in PAD severity [3 months]

    ankle-brachial pressure index

  2. Change in muscle size [3 months]

    Size of vastus lateralis measured via ultrasound

  3. Change in strength [3 months]

    Unilateral isometric maximal voluntary contraction

  4. Change in walk ability [3 months]

    Measured via the 6-minute walk test

  5. Change in physical function [3 months]

    Measured via timed up-and-go test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men and women with PAD 6 months post diagnosis.

  • Ankle-brachial pressure index <0.9.

  • People physically able to perform leg press and leg extension resistance exercise.

Exclusion Criteria:
  • Ankle-brachial pressure index >0.89.

  • People unable to visit the laboratory twice weekly for exercise sessions.

  • People unable to do leg press and leg extension exercise.

  • People whose walking is limited by a non-PAD condition.

  • People with PAD with critical limb ischemia (including symptoms of pain at rest and skin ulcers).

  • People with Dementia.

  • People who have had major surgery or myocardial infarction within the past 6 months.

  • Previous stroke.

  • Previous thrombosis.

  • People who have major surgery scheduled during the intervention period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheffield Hallam University Sheffield South Yorkshire United Kingdom s10 2BP

Sponsors and Collaborators

  • Sheffield Hallam University
  • Sheffield Teaching Hospitals NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheffield Hallam University
ClinicalTrials.gov Identifier:
NCT04890275
Other Study ID Numbers:
  • ER15905458
First Posted:
May 18, 2021
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sheffield Hallam University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2021